Luciferase Reporter Cell Line - SH-SY5Y

SH-SY5Y cells are a human-derived neuroblastoma cell line commonly used as an in vitro model for neuronal function and neurodegenerative disease research. Originating from a metastatic bone marrow site of neuroblastoma, SH-SY5Y cells display a mixed adrenergic and dopaminergic phenotype and can be induced to differentiate into neuron-like cells under specific culture conditions, such as treatment with retinoic acid. They exhibit neuronal morphology after differentiation, including neurite extension and increased expression of neuronal markers. The Luciferase Reporter Cell Line – SH-SY5Y is constructed by stably integrating a luciferase reporter gene under the control of defined response elements or pathway-specific promoters, allowing quantitative monitoring of transcriptional regulation in a neuronal cellular context while retaining the intrinsic biological properties of the parental SH-SY5Y line.

The Luciferase Reporter Cell Line – SH-SY5Y is widely applied in neuroscience, neuropharmacology, and neurotoxicity studies. It is particularly valuable for investigating signaling pathways associated with neuronal differentiation, oxidative stress, apoptosis, and synaptic plasticity, including MAPK/ERK, PI3K/AKT, and cAMP-responsive signaling cascades. The luciferase reporter system provides a sensitive and reproducible readout for evaluating pathway activation or inhibition following compound treatment or genetic manipulation. This makes the model well-suited for high-throughput screening of neuroactive compounds, neuroprotective agents, and potential therapeutic candidates for neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease. In addition, it is frequently used to assess mechanism-of-action, compound efficacy, and cellular stress responses, supporting both fundamental neuroscience research and early-stage drug development efforts.